Hepatitis B Immune Globulin Not Yet Recruiting Phase 4 Trials for Viral Hepatitis B / Transplantation, Liver Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02417207Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation